Mono Pharmacare
MONOPHARMA NSE
Mono Pharmacare
HealthcareNSE: MONOPHARMA Pharmaceuticals
Key Fundamentals
SMEPharmaceuticalsHealthcareMarket Cap
₹15.81 Cr
Volatility
Moderate
P/E Ratio
44.8
EBITDA
₹3.99 Cr
Return on Equity
9.94%
Debt to Equity
1.75
Book Value
₹17.86
EPS
₹1.38
52W High
₹25.5
52W Low
₹7.5
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Stock is trading at 0.50 times its book value
Weaknesses
5- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Company has a low return on equity of 7.18% over last 3 years.
- Company might be capitalizing the interest cost
- Company has high debtors of 165 days.
Growth Rate
Revenue Growth
-2.13% lower than
3Y
Net Income Growth
-89.68% lower than
3Y
Cash Flow Change
50.97% lower than
3Y
ROE
13.73% higher than
3Y
ROCE
6.39% lower than
3Y
EBITDA Margin (Avg.)
-52.65% higher than
3Y
Quarterly Results
| Particulars | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 35 | 67 | 56 | 87 | 81 | 66 | 99 |
| Expenses | 33 | 63 | 53 | 82 | 78 | 65 | 97 |
| Operating Profit | 2 | 4 | 2 | 5 | 3 | 2 | 2 |
| OPM % | 6% | 6% | 4.4% | 5% | 3.6% | 2.7% | 2.2% |
| Other Income | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Interest | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 1 | 2 | 1 | 3 | 1 | 0 | 0 |
| Tax % | 39% | 20% | 33% | 27% | 37% | 83% | 29% |
| Net Profit | 1 | 2 | 1 | 2 | 1 | 0 | 0 |
| EPS in Rs | 0.52 | 1.06 | 0.33 | 1.3 | 0.46 | 0.01 | 0.19 |
Profit & Loss
| Particulars | Mar 2023 6m | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 33 | 122 | 168 | 166 |
| Expenses | 31 | 116 | 161 | 162 |
| Operating Profit | 2 | 6 | 8 | 4 |
| OPM % | 7% | 5% | 4.5% | 2.4% |
| Other Income | 0 | 0 | 1 | 0 |
| Interest | 1 | 3 | 4 | 3 |
| Depreciation | 0 | 0 | 0 | 0 |
| PBT | 1 | 3 | 4 | 1 |
| Tax % | 29% | 24% | 30% | 40% |
| Net Profit | 1 | 2 | 3 | 0 |
| EPS in Rs | 0.76 | 1.38 | 1.75 | 0.2 |
| Div. Payout % | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 12 | 18 | 18 | 18 |
| Reserves | 1 | 10 | 14 | 14 |
| Borrowings | 40 | 41 | 54 | 56 |
| Other Liabilities | 9 | 12 | 25 | 34 |
| Total Liabilities | 63 | 81 | 110 | 122 |
| Fixed Assets | 1 | 1 | 1 | 1 |
| CWIP | 0 | 0 | 0 | 0 |
| Investments | 1 | 0 | 0 | 0 |
| Other Assets | 61 | 80 | 109 | 121 |
| Total Assets | 63 | 81 | 110 | 122 |
Cash Flow
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Operating | -40 | -9 | -4 | 2 |
| Investing | -1 | 0 | 0 | 0 |
| Financing | 41 | 8 | 5 | -2 |
| Net Cash Flow | 0 | 0 | 0 | 0 |
| Free Cash Flow | -40 | -9 | -5 | 2 |
| CFO/OP | -1,765 | -127 | -38 | 64 |
Ratios
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Debtor Days | 241 | 94 | 91 | 165 |
| Inventory Days | 408 | 139 | 133 | 99 |
| Days Payable | 87 | 32 | 45 | 68 |
| Cash Conversion Cycle | 563 | 202 | 179 | 196 |
| Working Capital Days | 299 | 131 | 120 | 126 |
| ROCE % | — | 10% | 11% | 5% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Mono Pharmacare insights
55 extracted metrics + investor summaries across FY22–FY25.
Documents
1
Updates
9 Sep - NSE levied ₹1,71,100 and ₹31,860 fines for delayed SEBI compliance filings. 9 Sep - NSE levied ₹1,71,100 and ₹31,860 fines for delayed SEBI compliance filings.
2
Shareholders meeting
4 Sep - 4th AGM on 30 Sep 2026; shareholders to approve Rs. 80 crore related-party transactions and auditor reappointment. 4 Sep - 4th AGM on 30 Sep 2026; shareholders to approve Rs. 80 crore related-party transactions and auditor reappointment.
3
Outcome of Board Meeting
3 Sep - Board met on 3 September 2026; approved AGM on 30 September, auditor appointment, record date 23 September. 3 Sep - Board met on 3 September 2026; approved AGM on 30 September, auditor appointment, record date 23 September.
4
Resignation
16 Jul - Mono Pharmacare Limited has informed regarding Resignation of Mr Rahul Joshi as Company Secretary & Compliance Officer of the company w.e.f. July 01, 2026. 16 Jul - Mono Pharmacare Limited has informed regarding Resignation of Mr Rahul Joshi as Company Secretary & Compliance Officer of the company w.e.f. July 01, 2026.
5
Outcome of Board Meeting
16 Jul - Board approved FY26 audited standalone and consolidated results; noted company secretary resignation and auditor appointments on 16 July 2026. 16 Jul - Board approved FY26 audited standalone and consolidated results; noted company secretary resignation and auditor appointments on 16 July 2026.
Frequently Asked Questions about Mono Pharmacare
What does Mono Pharmacare Ltd do?
Incorporated in 1994, Mono Pharmacare Ltd is in the business of distribution of Pharmaceutical items[1]
Where is Mono Pharmacare Ltd (MONOPHARMA) listed?
Mono Pharmacare Ltd trades as MONOPHARMA on the NSE.
Which sector does Mono Pharmacare Ltd belong to?
Mono Pharmacare Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Mono Pharmacare Ltd?
Mono Pharmacare Ltd has a market capitalisation of ₹15.81 Cr, which places it in the Small Cap band.
What is the PE ratio of Mono Pharmacare Ltd?
Mono Pharmacare Ltd trades at a PE ratio of 44.80, on earnings per share of ₹1.38, against a book value of ₹17.86 per share.
What is the 52-week high and low of Mono Pharmacare Ltd?
Over the last 52 weeks Mono Pharmacare Ltd has traded between ₹7.5 and ₹25.5.
What is the Return on Equity (ROE) of Mono Pharmacare Ltd?
Mono Pharmacare Ltd reported a return on equity of 9.94%. Its debt-to-equity ratio is 1.75.
Company Information
Incorporated in 1994, Mono Pharmacare Ltd is in the business of distribution of Pharmaceutical items[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/MONOPHARMA.md for Mono Pharmacare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.